Schizophrenia
Top Stories
FDA Approves Long-Acting Olanzapine Injection
The US Food and Drug Administration (FDA) has approved olanzapine extended-release intramuscular injection (Zyprexa Relprevv, Eli Lilly & Company) for…
Read MoreExercise May Increase Hippocampal Volume for Patients With Schizophrenia
In fact, the volume increased by 12% in those with schizophrenia and by 16% in those without and was associated…
Read MoreMother’s Flu During Pregnancy May Increase Baby’s Risk Of Schizophrenia
Rhesus monkey babies born to mothers who had the flu while pregnant had smaller brains and showed other brain changes…
Read MoreResearch Projects
The Year in Psychosis and Bipolar Disorder: Treating Antipsychotic-related Metabolic Abnormalities
Maayan and Colleagues. 2010: Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and…
Read MoreThe Year in Psychosis and Bipolar Disorder: Antipsychotic Cardiovascular Adverse Events
Antipsychotic-related weight gain and cardiometabolic adverse events are among the greatest challenges in treating patients with schizophrenia. Much still needs…
Read MoreThe Year in Psychosis and Bipolar Disorder: Maintenance Treatment in Schizophrenia
Wang and Colleagues. 2010: Risperidone Maintenance Treatment in Schizophrenia: A Randomized, Controlled Trial[9] Practice guidelines regarding the optimal dose of…
Read MoreJournals
Schizophrenia Research ,Volume 124, Issues 1-3 (december 2010)
The main Features in this Issue are:-Clinical significance of neurological soft signs in schizophrenia: Factor analysis of the Neurological Evaluation…
Read MoreSchizophrenia Research ,Volume 123, Issues 2-3 (November 2010)
The main Features in this Issue are: -Aberrant salience network (bilateral insula and anterior cingulate cortex) connectivity during information processing…
Read MoreSchizophrenia Research ,Volume 123, Issue 1, (October 2010)
The main Features in this Issue are: – Regional prefrontal cortex gray matter volumes in youth at familial risk for…
Read MoreCochrane Review
Schizophrenia and treatment option
Tells that there is not enough reliable treatment for schizophrenia, talking about clozapine and aripiprazole particularly More Details>> Username: saudipsych…
Read MoreDepot haloperidol decanoate for schizophrenia – (01/20/2010 )
Schizophrenia affects about one in 10000 people per year, and the lifetime prevalence is approximately one percent (Jablensky 1992). It…
Read MoreSulpiride for schizophrenia – (01/20/2010 )
The effectiveness of drugs such as chlorpromazine and haloperidol for symptoms of schizophrenia, led to the theory that a specific…
Read MoreCME
Exercise Beneficial for Physical and Mental Health Outcomes in Schizophrenia
May 25, 2010 – Regular physical exercise programs for individuals with schizophrenia and schizophrenia-like illnesses are feasible and may help improve…
Read MoreTreatment of Early-Onset Schizophrenia
Purpose of review: Treatment of children who develop schizophrenia in childhood and early adolescence presents unique considerations. There has been…
Read MoreExercise Beneficial for Physical and Mental Health Outcomes in Schizophrenia
May 25, 2010 – Regular physical exercise programs for individuals with schizophrenia and schizophrenia-like illnesses are feasible and may help improve…
Read More